J. Goldman & CO LP Scholar Rock Holding Corp Transaction History
J. Goldman & CO LP
- $3.21 Billion
- Q3 2024
A detailed history of J. Goldman & CO LP transactions in Scholar Rock Holding Corp stock. As of the latest transaction made, J. Goldman & CO LP holds 20,350 shares of SRRK stock, worth $839,437. This represents 0.01% of its overall portfolio holdings.
Number of Shares
20,350
Previous 171,094
88.11%
Holding current value
$839,437
Previous $1.43 Million
88.56%
% of portfolio
0.01%
Previous 0.04%
Shares
3 transactions
Others Institutions Holding SRRK
# of Institutions
175Shares Held
75.6MCall Options Held
585KPut Options Held
862K-
Siren, L.L.C. New York, NY11.3MShares$464 Million4.51% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD8.65MShares$357 Million0.01% of portfolio
-
Samsara Bio Capital, LLC Palo Alto, CA6.79MShares$280 Million31.52% of portfolio
-
Black Rock Inc. New York, NY5.66MShares$234 Million0.0% of portfolio
-
Redmile Group, LLC San Francisco, CA5.24MShares$216 Million2.74% of portfolio
About Scholar Rock Holding Corp
- Ticker SRRK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 51,640,600
- Market Cap $2.13B
- Description
- Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery and development of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of latent myostatin that has completed the Phase 3 clini...